News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Certara Corporation Conducts Model-Based Meta-Analysis To Compare The Efficacy And Tolerability Of Two Chronic Nonmalignant Pain Medications


2/24/2014 9:27:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. LOUIS, Mo.--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced today that its model-based meta-analysis comparing tramadol with tapentadol for the treatment of chronic nonmalignant pain has been published in the journal Pain and Therapy. This study provides an indirect comparison of the efficacy and tolerability profiles of the two medications. The resulting peer-reviewed paper is now available online at http://link.springer.com/article/10.1007/s40122-014-0023-5.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES